262 related articles for article (PubMed ID: 17997974)
41. Suppressor of cytokine signaling 1 interacts with oncogenic lymphocyte-specific protein tyrosine kinase.
Venkitachalam S; Chueh FY; Leong KF; Pabich S; Yu CL
Oncol Rep; 2011 Mar; 25(3):677-83. PubMed ID: 21234523
[TBL] [Abstract][Full Text] [Related]
42. The SOCS box-adapting proteins for ubiquitination and proteasomal degradation.
Linossi EM; Nicholson SE
IUBMB Life; 2012 Apr; 64(4):316-23. PubMed ID: 22362562
[TBL] [Abstract][Full Text] [Related]
43. Ankyrin repeat and SOCS box 3 (ASB3) mediates ubiquitination and degradation of tumor necrosis factor receptor II.
Chung AS; Guan YJ; Yuan ZL; Albina JE; Chin YE
Mol Cell Biol; 2005 Jun; 25(11):4716-26. PubMed ID: 15899873
[TBL] [Abstract][Full Text] [Related]
44. Deletion of the SOCS box of suppressor of cytokine signaling 3 (SOCS3) in embryonic stem cells reveals SOCS box-dependent regulation of JAK but not STAT phosphorylation.
Boyle K; Zhang JG; Nicholson SE; Trounson E; Babon JJ; McManus EJ; Nicola NA; Robb L
Cell Signal; 2009 Mar; 21(3):394-404. PubMed ID: 19056487
[TBL] [Abstract][Full Text] [Related]
45. Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function.
Stebbins CE; Kaelin WG; Pavletich NP
Science; 1999 Apr; 284(5413):455-61. PubMed ID: 10205047
[TBL] [Abstract][Full Text] [Related]
46. SOCS-6 binds to insulin receptor substrate 4, and mice lacking the SOCS-6 gene exhibit mild growth retardation.
Krebs DL; Uren RT; Metcalf D; Rakar S; Zhang JG; Starr R; De Souza DP; Hanzinikolas K; Eyles J; Connolly LM; Simpson RJ; Nicola NA; Nicholson SE; Baca M; Hilton DJ; Alexander WS
Mol Cell Biol; 2002 Jul; 22(13):4567-78. PubMed ID: 12052866
[TBL] [Abstract][Full Text] [Related]
47. Twenty proteins containing a C-terminal SOCS box form five structural classes.
Hilton DJ; Richardson RT; Alexander WS; Viney EM; Willson TA; Sprigg NS; Starr R; Nicholson SE; Metcalf D; Nicola NA
Proc Natl Acad Sci U S A; 1998 Jan; 95(1):114-9. PubMed ID: 9419338
[TBL] [Abstract][Full Text] [Related]
48. Selective assembly of HIV-1 Vif-Cul5-ElonginB-ElonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines.
Yu Y; Xiao Z; Ehrlich ES; Yu X; Yu XF
Genes Dev; 2004 Dec; 18(23):2867-72. PubMed ID: 15574593
[TBL] [Abstract][Full Text] [Related]
49. Essential role for the d-Asb11 cul5 Box domain for proper notch signaling and neural cell fate decisions in vivo.
Sartori da Silva MA; Tee JM; Paridaen J; Brouwers A; Runtuwene V; Zivkovic D; Diks SH; Guardavaccaro D; Peppelenbosch MP
PLoS One; 2010 Nov; 5(11):e14023. PubMed ID: 21124961
[TBL] [Abstract][Full Text] [Related]
50. The structure of SOCS3 reveals the basis of the extended SH2 domain function and identifies an unstructured insertion that regulates stability.
Babon JJ; McManus EJ; Yao S; DeSouza DP; Mielke LA; Sprigg NS; Willson TA; Hilton DJ; Nicola NA; Baca M; Nicholson SE; Norton RS
Mol Cell; 2006 Apr; 22(2):205-16. PubMed ID: 16630890
[TBL] [Abstract][Full Text] [Related]
51. A new high affinity binding site for suppressor of cytokine signaling-3 on the erythropoietin receptor.
Hörtner M; Nielsch U; Mayr LM; Heinrich PC; Haan S
Eur J Biochem; 2002 May; 269(10):2516-26. PubMed ID: 12027890
[TBL] [Abstract][Full Text] [Related]
52. Molecular characterization and immune response of suppressor of cytokine signaling 5b from redlip mullet (Planiliza haematocheilus): Disclosing its anti-viral potential and effect on cell proliferation.
Wijerathna HMSM; Nadarajapillai K; Shanaka KASN; Kasthuriarachchi TDW; Jung S; Lee S; Lee J
Fish Shellfish Immunol; 2023 Mar; 134():108629. PubMed ID: 36822381
[TBL] [Abstract][Full Text] [Related]
53. SOCS: physiological suppressors of cytokine signaling.
Krebs DL; Hilton DJ
J Cell Sci; 2000 Aug; 113 ( Pt 16)():2813-9. PubMed ID: 10910765
[TBL] [Abstract][Full Text] [Related]
54. MicroRNA-106a-3p Induces Apatinib Resistance and Activates Janus-Activated Kinase 2 (JAK2)/Signal Transducer and Activator of Transcription 3 (STAT3) by Targeting the SOCS System in Gastric Cancer.
Guo W; Li W; Yuan L; Mei X; Hu W
Med Sci Monit; 2019 Dec; 25():10122-10128. PubMed ID: 31884511
[TBL] [Abstract][Full Text] [Related]
55. SOCS proteins: negative regulators of cytokine signaling.
Krebs DL; Hilton DJ
Stem Cells; 2001; 19(5):378-87. PubMed ID: 11553846
[TBL] [Abstract][Full Text] [Related]
56. SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2.
Rui L; Yuan M; Frantz D; Shoelson S; White MF
J Biol Chem; 2002 Nov; 277(44):42394-8. PubMed ID: 12228220
[TBL] [Abstract][Full Text] [Related]
57. The suppressor of cytokine signaling (SOCS) 1 and SOCS3 but not SOCS2 proteins inhibit interferon-mediated antiviral and antiproliferative activities.
Song MM; Shuai K
J Biol Chem; 1998 Dec; 273(52):35056-62. PubMed ID: 9857039
[TBL] [Abstract][Full Text] [Related]
58. Identification of a Cullin5-ElonginB-ElonginC E3 complex in degradation of feline immunodeficiency virus Vif-mediated feline APOBEC3 proteins.
Wang J; Zhang W; Lv M; Zuo T; Kong W; Yu X
J Virol; 2011 Dec; 85(23):12482-91. PubMed ID: 21957297
[TBL] [Abstract][Full Text] [Related]
59. In vitro ubiquitination of cytokine signaling components.
Babon JJ; Laktyushin A; Kershaw NJ
Methods Mol Biol; 2013; 967():261-71. PubMed ID: 23296736
[TBL] [Abstract][Full Text] [Related]
60. Targeting Lyn tyrosine kinase through protein fusions encompassing motifs of Cbp (Csk-binding protein) and the SOCS box of SOCS1.
Whiting RJ; Payne CJ; Satiaputra J; Kucera N; Qiu TW; Irtegun S; Gunn NJ; Slavova-Azmanova NS; Mulhern TD; Ingley E
Biochem J; 2012 Mar; 442(3):611-20. PubMed ID: 22364282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
